He & She MD vs Telos Rx: Which GLP-1 Program Fits You
He & She MD vs Telos Rx: quick verdict first. If you want bundled clinician messaging, coaching and tracking with introductory pricing for six months, He & She MD emphasizes that model. If your priority is a lower listed starting price and month-to-month cancellation language, Telos Rx advertises semaglutide as low as $99/month, with treatment subject to approval by a licensed provider.
See He & She MD introductory plans
Overview: He & She MD vs Telos Rx
This comparison focuses on features both sites list: pricing and promotional structure, bundled clinical support, medication formats available, and regulatory notes about compounded medicines. Both providers offer compounded semaglutide and tirzepatide subject to clinician review, and both state that compounded medications are not FDA-approved.
Three distinctive differences that matter
1. Pricing structure and promotional terms
He & She MD lists semaglutide injections starting at $139/month and oral semaglutide or tirzepatide at $199/month as six-month introductory rates that renew higher. He & She MD explicitly warns those headline prices are six-month intro rates that renew 30 to 45 percent higher.
Telos Rx advertises semaglutide as low as $99/month and tirzepatide as low as $139/month, with pricing dependent on approval by a licensed provider. Telos Rx also states you may pay $0 if not approved and lists cancel anytime, no penalties language for plans.
Check Telos Rx pricing and eligibility
2. Clinical support and coaching
He & She MD bundles a coaching app that includes 1:1 clinician messaging, GLP-1-specific coaching and progress tracking at no extra cost. The provider frames its program as medications plus built-in support rather than selling coaching separately. Telos Rx describes medication prescribed after review by a US-licensed provider but does not capture bundled coaching or 1:1 messaging on the sourced page.
View He & She MD coaching features
3. Medication formats and clinical selection
He & She MD offers three formats on its landing evidence: semaglutide injection, oral semaglutide, and tirzepatide injection. Telos Rx emphasizes semaglutide and tirzepatide options and explains tirzepatide acts on GLP-1 and GIP while semaglutide acts on GLP-1, with a US-licensed provider deciding which is appropriate.
4. Cancellation, terms and renewal transparency
He & She MD structures pricing as six-month terms with promotional introductory rates for the first six months and higher renewal prices thereafter. Telos Rx uses language that treatment is subject to clinician approval and that customers can cancel anytime with no penalties, while other terms such as renewal pricing and state coverage were not published on the captured Telos Rx landing page.
| Criteria | He & She MD | Telos Rx |
|---|---|---|
| Starting listed price | $139/month for semaglutide injection introductory | Semaglutide as low as $99/month |
| Tirzepatide listed price | $199/month introductory | As low as $139/month |
| Coaching and clinician messaging | 1:1 clinician messaging and GLP-1 coaching included in app | Prescribed after review by a US-licensed provider; coaching not listed |
| Price term notes | Six-month introductory rates that renew higher | Pricing depends on plan and approval; cancel anytime language |
| Medication regulatory note | Compounded meds not reviewed by FDA | Compounded meds not FDA-approved |
| Shipping and fees | Free expedited shipping; no membership fee | Not fully published on captured page |
How they compare for common buyer priorities
Lowest upfront price
Telos Rx lists the lower headline starting price with semaglutide as low as $99/month, if a licensed provider approves you. He & She MD advertises a competitive introductory price but those are promotional six-month rates that renew higher.
Built-in coaching and ongoing support
He & She MD specifically bundles an app with 1:1 clinician messaging, GLP-1 coaching and progress tracking at no added cost, which it highlights as the program differentiator. Telos Rx centers provider review and prescription decisions but does not capture the same bundled coaching claim in the source material.
Regulatory and eligibility notes
Both providers state compounded semaglutide and tirzepatide are prescription-only and that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Telos Rx emphasizes that a US-licensed provider decides whether a medication is appropriate and lists that your price depends on your plan and approval.
Bottom line: He & She MD vs Telos Rx
He & She MD vs Telos Rx comes down to whether you prioritize bundled coaching and clinician messaging with promotional six-month pricing or a lower advertised starting rate with plan-dependent approval terms. He & She MD bundles coaching, clinician access and progress tracking and makes clear its headline prices are six-month intro rates that renew higher. Telos Rx advertises semaglutide from $99/month and tirzepatide from $139/month, with treatment and price subject to approval by a licensed provider and additional plan terms.
Review Telos Rx eligibility details
Choose He & She MD if…
You want GLP-1 medication bundled with an app, 1:1 clinician messaging, GLP-1-specific coaching and progress tracking included at no extra cost and accept that headline prices are six-month introductory rates that renew higher.
Choose Telos Rx if…
You prioritize the lowest advertised starting price and want a plan that lists semaglutide as low as $99/month and tirzepatide as low as $139/month, with the understanding that treatment, state coverage and final price depend on approval by a licensed provider and plan terms.
Primary keyword: He & She MD vs Telos Rx